Ruzasvir is a direct-acting antiviral agent within the NS5A inhibitor class, designed to treat chronic Hepatitis C infection by targeting the NS5A protein to disrupt viral replication. This category contains… Read more
Ruzasvir is a direct-acting antiviral agent within the NS5A inhibitor class, designed to treat chronic Hepatitis C infection by targeting the NS5A protein to disrupt viral replication. This category contains essential Ruzasvir reference standards, including the active pharmaceutical ingredient, relevant pharmacopeial and non-pharmacopeial impurities, and metabolites. Analytical laboratories utilize these compounds to conduct rigorous impurity profiling and method validation, ensuring the consistency and safety of drug formulations. Additionally, stable isotope labelled versions of Ruzasvir are available for use as internal standards in liquid chromatography-mass spectrometry (LC-MS) assays, providing the precision required for quantitative bioanalysis. By incorporating these high-quality reference materials, researchers and quality control scientists can effectively monitor degradation products and verify drug purity throughout the various stages of pharmaceutical development and manufacturing.